Analysis of Common Treatment Drugs and Allergen Sensitization in Hair Loss Patients

    February 2025 in “ Journal of Cosmetic Dermatology
    Chengcheng Feng, Ying Wang, Dingquan Yang, Hui Shen
    Image of study
    TLDR Patch testing is crucial to reduce allergic reactions in hair loss treatments.
    The study examined allergen sensitization in 196 hair loss patients through patch tests, focusing on common hair loss types and treatment drugs. Results indicated that 7 cosmetic ingredients, including preservatives and metals, were prone to sensitization. Notably, dodecyl polyglucoside had a 10.20% positivity rate, while metal allergens cobalt chloride and nickel sulfate had rates of 56.63% and 32.65%. Topical medications like ketoconazole lotion showed a 50.00% positivity rate. Minoxidil formulations had significant sensitization potential, with rates decreasing when combined with hydrocortisone. The study underscores the importance of patch testing to minimize allergic reactions and improve treatment compliance, advocating for personalized treatment approaches. Limitations include potential errors from varying concentrations, suggesting a need for larger-scale studies.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 22 results

      community Crown slowly coming back from the dead

      in Is this regrowth?  111 upvotes 1 day ago
      A user shared their hair regrowth journey using a comprehensive treatment plan including oral minoxidil, oral dutasteride, topical minoxidil, Nizoral shampoo, microneedling, and various supplements. They reported noticeable improvement in their crown area after 4.5 months, with only minor side effects like forehead pimples.

      community Warning: Minoxidil usage around pets

      in Minoxidil  454 upvotes 9 months ago
      Minoxidil is highly toxic to pets, especially cats and dogs, even in small amounts. Many users have switched to oral minoxidil to prevent accidental exposure to their pets.

      community Allergan recruiting for Setipiprant trial in the US

       12 upvotes 8 years ago
      The conversation discusses a clinical trial for Setipiprant in the US, starting June 29th, with eligibility excluding recent users of minoxidil or finasteride. It encourages informed decision-making before signing up.

      community Low level chronic allergies and hair loss

      in Research/Science  6 upvotes 1 year ago
      Hair loss can be influenced by chronic low-level allergies, and treatments like fexofenadine or topical cetirizine may help with regrowth. The user avoids finasteride, dutasteride, and minoxidil, and has tried Regenera Activa and PRF sessions.

      community New treatment? Minox + Bimatoprost

      in Treatment  7 upvotes 1 year ago
      A user discussed a new hair loss treatment combining 5% Minoxidil with Bimatoprost 0.3mg/ml, applied once daily. They referenced a study suggesting Bimatoprost may be more effective than Minoxidil.

    Related Research

    4 / 4 results